These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI. Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319 [Abstract] [Full Text] [Related]
4. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR. Kagawa Y, Okada M, Kumano S, Katsube T, Imaoka I, Tanigawa N, Ishii K, Kudo M, Murakami T. J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951 [Abstract] [Full Text] [Related]
5. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? Haradome H, Grazioli L, Al manea K, Tsunoo M, Motosugi U, Kwee TC, Takaraha T. J Magn Reson Imaging; 2012 Jan; 35(1):132-9. PubMed ID: 21960465 [Abstract] [Full Text] [Related]
11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [Abstract] [Full Text] [Related]
12. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. Filippone A, Blakeborough A, Breuer J, Grazioli L, Gschwend S, Hammerstingl R, Heinz-Peer G, Kittner T, Laghi A, Leen E, Lencioni R, Lucidarme O, Remplik P, Robinson PJ, Ruehm SG, Schaefer F, Stoupis C, Tombach B, Valette PJ, Zech CJ, Huppertz A. J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349 [Abstract] [Full Text] [Related]
17. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Motosugi U, Ichikawa T, Onohara K, Sou H, Sano K, Muhi A, Araki T. Invest Radiol; 2011 Jun; 46(6):359-65. PubMed ID: 21427594 [Abstract] [Full Text] [Related]
18. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, Araki T. J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436 [Abstract] [Full Text] [Related]
20. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience. Lee SA, Lee CH, Jung WY, Lee J, Choi JW, Kim KA, Park CM. Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227 [Abstract] [Full Text] [Related] Page: [Next] [New Search]